Aclaris Therapeutics (ACRS) Other Gross PP&E Adjustments (2017 - 2025)
Aclaris Therapeutics (ACRS) has 9 years of Other Gross PP&E Adjustments data on record, last reported at -$20.1 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 51.21% year-over-year to -$20.1 million; the TTM value through Sep 2025 reached $5.8 million, changed 0.31%, while the annual FY2025 figure was -$20.1 million, 51.21% down from the prior year.
- Other Gross PP&E Adjustments reached -$20.1 million in Q4 2025 per ACRS's latest filing, down from $5.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $6.3 million in Q3 2023 and bottomed at -$20.1 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is $396600.0, with a median of $5.0 million recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: increased 27.18% in 2023, then tumbled 51.21% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$13.0 million in 2021, then dropped by 9.98% to -$14.3 million in 2022, then grew by 14.16% to -$12.3 million in 2023, then dropped by 8.27% to -$13.3 million in 2024, then crashed by 51.21% to -$20.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$20.1 million in Q4 2025, $5.8 million in Q3 2025, and $5.9 million in Q2 2025.